Panther Life Sciences Appoints Mounir Hanana as Chief Executive Officer

Panther Life Sciences Appoints Mounir Hanana as Chief Executive Officer

Hanana joins as Panther begins commercializing its SmartPatch™ platform, starting with cosmetics & medical aesthetics and expanding to therapeutic applications.

NEW YORK, NY, UNITED STATES, September 9, 2026 /EINPresswire.com/ -- Panther Life Sciences today announced the appointment of Marcus “Mounir” Hanana as Chief Executive Officer. Founder Carlos Bhola will continue as Executive Chairman, partnering closely with Hanana as Panther commercializes its SmartPatch™ platform across high-growth health, wellness and therapeutic markets, including dermatology and aesthetic applications.

“Beginning in late 2023 with a small, agile team, we combined innovations in skin biology with advanced engineering expertise to develop a delivery platform for next-generation treatments. We are now ready to deploy our SmartPatch, in 2027, which requires go-to-market and commercialization capabilities,” said Bhola. “We were intentional in our search for a partner with a track record of deploying global technology platforms, scaling manufacturing, and commercializing innovation—and we found that in Mounir. I am excited by what Panther will accomplish under Mounir’s direction and am looking forward to closely partnering with him.”

Hanana brings 25 years of global leadership experience across Procter & Gamble and Amazon. During his career, he has led initiatives ranging from several hundred million dollars in revenue to large global multibillion-dollar businesses, combining expertise in manufacturing, commercialization, technology platforms and operational scale. At Procter & Gamble, he helped bring consumer products from development to market through world-class manufacturing, supply chains and commercial organizations. At Amazon, he led large global technology businesses, most recently serving as CFO of Amazon Business, one of the company's fastest-growing global businesses. Together, these experiences span consumer products, advanced manufacturing, global technology platforms and operational excellence—capabilities critical for Panther’s next phase of commercialization.

“Having spent much of my career building and scaling global businesses, I know a category-defining opportunity when I see one,” said Hanana. “That is why I joined Panther. Our team has built a unique, powerful technology capable of transforming both consumer and medical markets. I am looking forward to partnering with Carlos as we build the operational foundation to bring this platform to consumers at scale.”

With Hanana leading Panther’s operations, commercialization and organizational growth, Bhola will focus on leading strategy, product vision and corporate development.

For more information, visit www.pantherls.com.

About Panther Life Sciences
Panther Life Sciences is building the leading skin-powered delivery platform for health, wellness and therapeutics. Its proprietary intradermal SmartPatch™ precisely delivers treatments through the skin, unlocking the skin as a scalable gateway for care. Panther’s AI-based platform accelerates product development and personalizes treatment and care, resulting in compelling provider and consumer experiences. Panther is led by a team of successful entrepreneurs and operators and is advised by leading scientific experts.

Madeleine Bumstead
AM Public Relations
mbumstead@ampublicrelations.com
Visit us on social media:
LinkedIn